Biotherapeutics
Search documents
Denali Therapeutics Inc. (DNLI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Seeking Alpha· 2026-01-14 05:45
Core Insights - Denali is focused on delivering biotherapeutics to the brain and has expanded its technology to target other regions of the body [2] - The company has seen significant maturation in both clinical and preclinical data, highlighting the effectiveness of using transferrin receptor technology for biotherapeutics [3] Company Overview - Denali was founded with the mission to develop biotherapeutics that can effectively access the brain [2] - The company is positioned in a competitive field, indicating a growing interest and activity in biotherapeutics targeting the central nervous system [3]
Why Exelixis (EXEL) is a Top Growth Stock for the Long-Term
ZACKS· 2025-05-15 14:50
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Sco ...